| Literature DB >> 22352782 |
Andrés A Trabanco1, Gary Tresadern, Gregor J Macdonald, Juan Antonio Vega, Ana Isabel de Lucas, Encarnación Matesanz, Aránzazu García, María Lourdes Linares, Sergio A Alonso de Diego, José Manuel Alonso, Daniel Oehlrich, Abdelah Ahnaou, Wilhelmus Drinkenburg, Claire Mackie, José Ignacio Andrés, Hilde Lavreysen, José María Cid.
Abstract
Advanced leads of an imidazopyridine series of positive allosteric modulators of the metabotropic glutamate 2 (mGlu2) receptor are reported. The optimization of in vitro ADMET and in vivo pharmacokinetic properties led to the identification of 27o. With good potency and selectivity for the mGlu2 receptor, 27o affected sleep-wake architecture in rats after oral treatment, which we have previously shown to be indicative of mGlu2 receptor-mediated central activity.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22352782 DOI: 10.1021/jm201561r
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446